Vistaril (hydroxyzine pamoate) Capsules and Oral Suspension
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) –
February 2016
CONTRAINDICATIONS
Hydroxyzine is contraindicated in patients with a prolonged QT interval.
PRECAUTIONS
...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Hydroxyzine